Results 241 to 250 of about 435,562 (349)

Predictive Value of Residual SYNTAX Score II for Patients With Complex Coronary Disease and Chronic Renal Insufficiency After Percutaneous Coronary Intervention. [PDF]

Rev Cardiovasc Med
Zhang S, Lei Y, Chen J, Wang Y, Liu H, Guo N, Wang Y, Cao X, Yan L.   +8 more
europepmc   +1 more source

[Chronic renal insufficiency].

Revista chilena de pediatria, 1978
C, Saieh, F, Puga, J, Weinberger
openaire   +1 more source

Efficacy and safety of benazepril for advanced chronic renal insufficiency.

New England Journal of Medicine, 2006
F. Hou, Xun Zhang, G. H. Zhang, D. Xie, Ping-yan Chen, Wei Zhang, Jian-ping Jiang, M. Liang, G. B. Wang, Zheng-rong Liu, R. Geng   +10 more
semanticscholar   +1 more source

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators

British Journal of Clinical Pharmacology, EarlyView.
Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen, Sean Hennessy, Colleen M. Brensinger, Warren B. Bilker, Laura M. Dember, Todd A. Miano, Tat‐Thang Vo, Allison W. Willis, Charles E. Leonard   +8 more
wiley   +1 more source

Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). [PDF]

Kidney Med
Schmidt IM, Kefalogianni E, Zhao R, Verma A, Sabbisetti V, Rahman M, Pradhan N, Srivastava A, He J, Chen J, Waikar SS, Herrlich A, CRIC Study Investigators.   +12 more
europepmc   +1 more source

Chronic Renal Insufficiency [PDF]

, 2010
openaire   +1 more source

Optimal dosing for vascular anomalies paediatric patients with population pharmacokinetic model of sirolimus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Sirolimus is currently used off‐label for paediatric patients with vascular anomalies. However, the optimal dosage regimen for paediatric patients remains controversial. This study aimed to determine the optimal dosing regimen of sirolimus in these patients using a population pharmacokinetic (PK) model.
Seongmee Jeong, Jungryul Kim, Woojin Jung, Jiyeon Jeon, Hyeongjun Jo, Kyoung‐Bin Ryu, Ja‐Young Hong, Kwan Soo Kim, Seongjun Yang, Hee Young Ju, Hwi‐yeol Yun, Jung‐woo Chae, Keon Hee Yoo, Soyoung Lee   +13 more
wiley   +1 more source

Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study. [PDF]

Clin J Am Soc Nephrol
Winkelman D, Smith-Gagen J, Rebholz CM, Gutierrez OM, St-Jules DE.   +4 more
europepmc   +1 more source

Supratherapeutic drug concentration triggers: A novel data‐driven approach to assess their value for medication safety surveillance in intensive care

British Journal of Clinical Pharmacology, EarlyView.
Aims Electronic triggers (e‐triggers) are used as screening signals to detect potential adverse drug events (ADEs) and offer an effective system level approach for medication safety surveillance. Their clinical utility is typically evaluated through time‐consuming manual chart review by experts, limiting implementation.
Anne Paulien Langermans, Izak A. R. Yasrebi‐de Kom, Dylan Wayne de Lange, Nicolette Fransisca de Keizer, Joanna E. Klopotowska, on behalf of the RESCUE Study group, C. S. C. Bouman, E. N. van Roon, P. F. Schutte, J. ten Cate, D. van Balen, S. Hendriks, C. Lau, W. J. Vermeijden, A. Beishuizen, J. B. Masselink, P. E. Spronk, H. J. M. van Kan, P. W. de Feiter, E. J. Wils, A. Wieringa, A. J. Valkenburg, W. M. van den Bergh, M. H. Renes, W. Bult, E. de Jonge, M. Hoeksema, E. J. Wesselink, I. M. Purmer, B. E. Bosma, S. H. W. van Bree, H. J. W. Lammers, R. J. Bosman, E. J. F. Franssen, A. Karakus, M. Sigtermans, E. M. Kuck, D. A. Dongelmans, M. J. H. Aries, E. V. Uijtendaal, M. C. Reuland   +40 more
wiley   +1 more source

Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China. [PDF]

MedComm (2020)
Peng C, Cao Q, Xiong F, Xu H, Li J.
europepmc   +1 more source